- Home
- BLFS vs USPH Comparison
BLFS vs USPH Comparison
Compare BLFS & USPH Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- BLFS
- USPH
- Stock Information
- Founded
- BLFS 1987
- USPH 1990
- Country
- BLFS United States
- USPH United States
- Employees
- BLFS N/A
- USPH N/A
- Industry
- BLFS Medical/Dental Instruments
- USPH Medical/Nursing Services
- Sector
- BLFS Health Care
- USPH Health Care
- Exchange
- BLFS Nasdaq
- USPH Nasdaq
- Market Cap
- BLFS 1.2B
- USPH 1.3B
- IPO Year
- BLFS 1989
- USPH 1992
- Fundamental
- Price
- BLFS $25.59
- USPH $79.00
- Analyst Decision
- BLFS Strong Buy
- USPH Strong Buy
- Analyst Count
- BLFS 7
- USPH 4
- Target Price
- BLFS $30.86
- USPH $110.25
- AVG Volume (30 Days)
- BLFS 423.5K
- USPH 117.0K
- Earning Date
- BLFS 11-11-2025
- USPH 11-04-2025
- Dividend Yield
- BLFS N/A
- USPH 2.29%
- EPS Growth
- BLFS N/A
- USPH 116.39
- EPS
- BLFS N/A
- USPH 2.29
- Revenue
- BLFS $93,468,000.00
- USPH $722,201,000.00
- Revenue This Year
- BLFS $26.07
- USPH $18.74
- Revenue Next Year
- BLFS $16.86
- USPH $6.07
- P/E Ratio
- BLFS N/A
- USPH $34.30
- Revenue Growth
- BLFS 68.16
- USPH 16.25
- 52 Week Low
- BLFS $19.10
- USPH $62.77
- 52 Week High
- BLFS $29.55
- USPH $101.20
- Technical
- Relative Strength Index (RSI)
- BLFS 54.16
- USPH 41.08
- Support Level
- BLFS $25.17
- USPH $78.18
- Resistance Level
- BLFS $27.52
- USPH $86.74
- Average True Range (ATR)
- BLFS 0.84
- USPH 2.10
- MACD
- BLFS -0.14
- USPH -0.94
- Stochastic Oscillator
- BLFS 36.76
- USPH 9.58
About BLFS BioLife Solutions Inc.
BioLife Solutions Inc is a life sciences company that develops, manufactures, and markets bioproduction products and services that are designed to improve quality and de-risk biologic manufacturing, distribution, and transportation in the cell and gene therapy ("CGT") industry. The company provides solutions such as Cell Processing, Cold Chain, and Thawing. The company generates the majority of its revenue from Cell Processing through the biopreservation product "CryoStor". Geographically the company generates the majority of its revenue from the United States.
About USPH U.S. Physical Therapy Inc.
US Physical Therapy Inc through its subsidiaries operates outpatient physical therapy clinics that provide pre-and post-operative care and treatment for orthopedic-related disorders, sports-related injuries, preventative care, rehabilitation of injured workers, and neurological-related injuries. The principal payment sources for the clinics' services are managed care programs, commercial health insurance, Medicare/Medicaid, workers' compensation insurance, and proceeds from personal injury cases. Its operating segment includes Physical therapy operations and Industrial injury prevention services. The company generates maximum revenue from the Physical therapy operations segment.